144 related articles for article (PubMed ID: 21102518)
1. Efficient in vivo microRNA targeting of liver metastasis.
Huynh C; Segura MF; Gaziel-Sovran A; Menendez S; Darvishian F; Chiriboga L; Levin B; Meruelo D; Osman I; Zavadil J; Marcusson EG; Hernando E
Oncogene; 2011 Mar; 30(12):1481-8. PubMed ID: 21102518
[TBL] [Abstract][Full Text] [Related]
2. Silencing of microRNAs in vivo with 'antagomirs'.
Krützfeldt J; Rajewsky N; Braich R; Rajeev KG; Tuschl T; Manoharan M; Stoffel M
Nature; 2005 Dec; 438(7068):685-9. PubMed ID: 16258535
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
Sarver AL; Li L; Subramanian S
Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
[TBL] [Abstract][Full Text] [Related]
4. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.
Esau C; Davis S; Murray SF; Yu XX; Pandey SK; Pear M; Watts L; Booten SL; Graham M; McKay R; Subramaniam A; Propp S; Lollo BA; Freier S; Bennett CF; Bhanot S; Monia BP
Cell Metab; 2006 Feb; 3(2):87-98. PubMed ID: 16459310
[TBL] [Abstract][Full Text] [Related]
5. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.
Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K
Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410
[TBL] [Abstract][Full Text] [Related]
6. miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide.
Jiang Y; Wu Y; Greenlee AR; Wu J; Han Z; Li X; Zhao Y
Toxicol Sci; 2011 Jan; 119(1):50-60. PubMed ID: 20889678
[TBL] [Abstract][Full Text] [Related]
7. Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol.
Melkamu T; Zhang X; Tan J; Zeng Y; Kassie F
Carcinogenesis; 2010 Feb; 31(2):252-8. PubMed ID: 19748927
[TBL] [Abstract][Full Text] [Related]
8. Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-miR-21 Delivery With an Activatable Luciferase Reporter.
Wang F; Zhang B; Zhou L; Shi Y; Li Z; Xia Y; Tian J
ACS Appl Mater Interfaces; 2016 Apr; 8(14):9014-21. PubMed ID: 27010367
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression profiles in human colorectal cancers with liver metastases.
Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
[TBL] [Abstract][Full Text] [Related]
10. The liver-specific microRNA miR-122: biology and therapeutic potential.
Filipowicz W; Grosshans H
Prog Drug Res; 2011; 67():221-38. PubMed ID: 21141732
[TBL] [Abstract][Full Text] [Related]
11. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.
Felicetti F; Errico MC; Bottero L; Segnalini P; Stoppacciaro A; Biffoni M; Felli N; Mattia G; Petrini M; Colombo MP; Peschle C; Carè A
Cancer Res; 2008 Apr; 68(8):2745-54. PubMed ID: 18417445
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K
Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999
[TBL] [Abstract][Full Text] [Related]
13. A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth.
Streicher KL; Zhu W; Lehmann KP; Georgantas RW; Morehouse CA; Brohawn P; Carrasco RA; Xiao Z; Tice DA; Higgs BW; Richman L; Jallal B; Ranade K; Yao Y
Oncogene; 2012 Mar; 31(12):1558-70. PubMed ID: 21860416
[TBL] [Abstract][Full Text] [Related]
14. Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.
Callegari E; Elamin BK; Giannone F; Milazzo M; Altavilla G; Fornari F; Giacomelli L; D'Abundo L; Ferracin M; Bassi C; Zagatti B; Corrà F; Miotto E; Lupini L; Bolondi L; Gramantieri L; Croce CM; Sabbioni S; Negrini M
Hepatology; 2012 Sep; 56(3):1025-33. PubMed ID: 22473819
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers.
Imam JS; Buddavarapu K; Lee-Chang JS; Ganapathy S; Camosy C; Chen Y; Rao MK
Oncogene; 2010 Sep; 29(35):4971-9. PubMed ID: 20603620
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells.
Lee CY; Rennie PS; Jia WW
Clin Cancer Res; 2009 Aug; 15(16):5126-35. PubMed ID: 19671871
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury.
Ye Y; Hu Z; Lin Y; Zhang C; Perez-Polo JR
Cardiovasc Res; 2010 Aug; 87(3):535-44. PubMed ID: 20164119
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of a highly-metastatic model of human primary melanoma of the small intestine orthotopically transplanted in the small intestine of nude mice].
Tuo CW; Zhang N; Liu QZ; Yang B; Wang MY
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):885-90. PubMed ID: 19173986
[TBL] [Abstract][Full Text] [Related]
19. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA silencing in primates: towards development of novel therapeutics.
Petri A; Lindow M; Kauppinen S
Cancer Res; 2009 Jan; 69(2):393-5. PubMed ID: 19147547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
